186 related articles for article (PubMed ID: 30693115)
1. Breast Cancer Development in a Transgender Male Receiving Testosterone Therapy.
Barghouthi N; Turner J; Perini J
Case Rep Endocrinol; 2018; 2018():3652602. PubMed ID: 30693115
[TBL] [Abstract][Full Text] [Related]
2. Breast Cancer in the Transgender Population.
Fehl A; Ferrari S; Wecht Z; Rosenzweig M
J Adv Pract Oncol; 2019; 10(4):387-394. PubMed ID: 33343986
[TBL] [Abstract][Full Text] [Related]
3. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer in transgender female-to-male individuals: A case report of androgen receptor-positive breast cancer.
Fundytus A; Saad N; Logie N; Roldan Urgoiti G
Breast J; 2020 May; 26(5):1007-1012. PubMed ID: 31749246
[TBL] [Abstract][Full Text] [Related]
5. A Dual-Surgeon Approach to Breast Cancer Surgery in a Transmale.
Parmeshwar N; Alcon A; Kim EA
Ann Plast Surg; 2021 Dec; 87(6):633-638. PubMed ID: 33723981
[TBL] [Abstract][Full Text] [Related]
6. Two Transgender Men Receiving Subdermal Testosterone Pellets for Gender Affirmation.
Wolf Pulsiano SL; Sarvaideo JL
AACE Clin Case Rep; 2023; 9(6):201-204. PubMed ID: 38045793
[TBL] [Abstract][Full Text] [Related]
7. Masculinizing hormone therapy effect on breast tissue: Changes in estrogen and androgen receptors in transgender female-to-male mastectomies.
Chaum M; Grossi S; Chen J; Hu V; Ray E; Giuliano A; Bose S
Breast; 2023 Dec; 72():103596. PubMed ID: 37951051
[TBL] [Abstract][Full Text] [Related]
8. Invasive Ductal Carcinoma of the Breast in a Transgender Man: A Case Report.
Heng YJ; Zhang KJ; Valero MG; Baker GM; Fein-Zachary VJ; Irwig MS; Wulf GM
Case Rep Oncol; 2023; 16(1):811-817. PubMed ID: 37900827
[TBL] [Abstract][Full Text] [Related]
9. Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy.
Silva ED; Fighera TM; Allgayer RM; Lobato MIR; Spritzer PM
Front Psychiatry; 2021; 12():621075. PubMed ID: 34381383
[No Abstract] [Full Text] [Related]
10. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
[TBL] [Abstract][Full Text] [Related]
12. Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: A systematic review.
Spanos C; Bretherton I; Zajac JD; Cheung AS
World J Diabetes; 2020 Mar; 11(3):66-77. PubMed ID: 32180895
[TBL] [Abstract][Full Text] [Related]
13. Systematic Review on Gender-Affirming Testosterone Therapy and the Risk of Breast Cancer: A Challenge for Physicians Treating Patients from Transgender and Gender-Diverse Populations.
Pamulapati S; Conroy M; Cortina C; Harding E; Kamaraju S
Arch Sex Behav; 2024 May; 53(5):1969-1980. PubMed ID: 38148450
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.
de Blok CJM; Wiepjes CM; Nota NM; van Engelen K; Adank MA; Dreijerink KMA; Barbé E; Konings IRHM; den Heijer M
BMJ; 2019 May; 365():l1652. PubMed ID: 31088823
[TBL] [Abstract][Full Text] [Related]
16. Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.
McFarlane T; Zajac JD; Cheung AS
Clin Endocrinol (Oxf); 2018 Dec; 89(6):700-711. PubMed ID: 30107028
[TBL] [Abstract][Full Text] [Related]
17. Prospective Evaluation of Self-Reported Aggression in Transgender Persons.
Defreyne J; T'Sjoen G; Bouman WP; Brewin N; Arcelus J
J Sex Med; 2018 May; 15(5):768-776. PubMed ID: 29699761
[TBL] [Abstract][Full Text] [Related]
18. Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy.
Mullins ES; Geer R; Metcalf M; Piccola J; Lane A; Conard LAE; Mullins TLK
Pediatrics; 2021 Apr; 147(4):. PubMed ID: 33753543
[TBL] [Abstract][Full Text] [Related]
19. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
Curigliano G; Criscitiello C
J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
[TBL] [Abstract][Full Text] [Related]
20. Mammary Myofibroblastoma in a Transgender Patient on Feminizing Hormones: Literature Review and Case Report.
O'Bryan J; Wolf-Gould C; Matsuo Y
Transgend Health; 2018; 3(1):1-9. PubMed ID: 29344575
[No Abstract] [Full Text] [Related]
[Next] [New Search]
